Paul Tudor Jones Veracyte, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Veracyte, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 40,873 shares of VCYT stock, worth $1.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,873
Previous 38,884
5.12%
Holding current value
$1.6 Million
Previous $842,000
65.08%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VCYT
# of Institutions
307Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$304 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$303 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$196 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$192 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$165 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.8B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...